OCULAR THERAPEUTIX INC (OCUL) Stock Analyst Ratings

USA • Nasdaq • NASDAQ:OCUL • US67576A1007

9.03 USD
-0.4 (-4.24%)
At close: Feb 10, 2026
9.2 USD
+0.17 (+1.88%)
Pre-Market: 2/11/2026, 8:57:54 AM
Buy % Consensus

86

ChartMill assigns a Buy % Consensus number of 86% to OCUL. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 24.82. This target is 174.86% above the current price.
  • OCUL was analyzed by 19 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about OCUL.
  • In the previous month the buy percentage consensus was at a similar level.
  • OCUL was analyzed by 19 analysts, which is quite many. So the average rating should be quite meaningful.
OCUL Historical Analyst RatingsOCUL Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15

Price Target & Forecast

Price Low Median Mean High 9.0320.2022.9524.8232.55 - 123.70% 154.15% 174.86% 260.47%
OCUL Current Analyst RatingOCUL Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10
Up and Down Grades
Date Firm Action Rating
2025-12-09 Chardan Capital Maintains Buy -> Buy
2025-12-08 Needham Reiterate Buy -> Buy
2025-12-08 HC Wainwright & Co. Maintains Buy -> Buy
2025-11-25 HC Wainwright & Co. Reiterate Buy -> Buy
2025-11-05 Chardan Capital Maintains Buy -> Buy
2025-10-30 TD Cowen Maintains Buy -> Buy
2025-10-08 HC Wainwright & Co. Maintains Buy -> Buy
2025-10-03 Baird Maintains Outperform -> Outperform
2025-10-03 Piper Sandler Maintains Overweight -> Overweight
2025-10-02 Chardan Capital Maintains Buy -> Buy
2025-10-01 JMP Securities Maintains Market Outperform -> Market Outperform
2025-10-01 Needham Maintains Buy -> Buy
2025-09-15 Chardan Capital Initiate Buy
2025-08-06 ScotiaBank Maintains Sector Outperform -> Sector Outperform
2025-08-05 Needham Maintains Buy -> Buy
2025-05-29 HC Wainwright & Co. Reiterate Buy -> Buy
2025-05-06 Needham Maintains Buy -> Buy
2025-04-08 William Blair Initiate Outperform
2025-04-08 Needham Reiterate Buy -> Buy
2025-03-18 RBC Capital Initiate Outperform
2025-03-11 Needham Initiate Buy
2025-03-04 Citizens Capital Markets Maintains Market Outperform -> Market Outperform
2025-03-04 HC Wainwright & Co. Reiterate Buy -> Buy
2024-12-03 HC Wainwright & Co. Reiterate Buy -> Buy
2024-11-15 HC Wainwright & Co. Maintains Buy -> Buy
2024-10-16 ScotiaBank Initiate Sector Outperform
2024-10-16 HC Wainwright & Co. Reiterate Buy -> Buy
2024-08-08 Baird Maintains Outperform -> Outperform
2024-08-01 HC Wainwright & Co. Reiterate Buy -> Buy
2024-06-21 Piper Sandler Maintains Overweight -> Overweight

OCULAR THERAPEUTIX INC / OCUL FAQ

What is the average price target for OCULAR THERAPEUTIX INC (OCUL) stock?

19 analysts have analysed OCUL and the average price target is 24.82 USD. This implies a price increase of 174.86% is expected in the next year compared to the current price of 9.03.


How do analysts rate OCULAR THERAPEUTIX INC (OCUL)?

The consensus rating for OCULAR THERAPEUTIX INC (OCUL) is 86.3158 / 100 . This indicates that analysts generally have a positive outlook on the stock.